Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 232 publications
Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026
Immunoglobulin D-Associated AL Amyloidosis: Clinical Features and Outcomes.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 29, 2026
Structural basis for the pro-amyloidogenic action and ligand binding of a novel W72R variant of human apolipoprotein A-I.
Journal: Journal of molecular biology
Published: March 31, 2026
A Clinically Applicable Conversion Formula between NT-proBNP and BNP in Light-Chain Amyloidosis.
Journal: JACC. CardioOncology
Published: March 16, 2026
Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.
Journal: Blood advances
Published: February 20, 2026
Cyclin D1 immunostaining as a diagnostic surrogate for the t(11;14) translocation in AL amyloidosis.
Cyclin D1 immunostaining as a diagnostic surrogate for the t(11;14) translocation in AL amyloidosis.
Journal: British journal of haematology
Published: February 20, 2026
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis.
Journal: Blood
Published: February 02, 2026
Past, Present, and Future of Dexamethasone in Multiple Myeloma and AL Amyloidosis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 27, 2026
Last Updated: 09/26/2026